178.41MUSD
Type
Common Stock
Exchange
PINK
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
-
CUSIP
-
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
1.29
Dividend Share
-
Dividend Yield
-
Earnings Share
-1.16
Wall Street Target Price
-
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
36,042,000
Gross Profit TTM
35,305,000
EBITDA
-67,215,000
Profit Margin
-234.39%
Return On Assets TTM
-16.09%
Return On Equity TTM
-82.20%
Revenue Per Share TTM
0.44
Qtly Revenue Growth YOY
998.00%
Diluted Eps TTM
-1.16
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
4.321
Price Book MRQ
0.9667
Enterprise Value Revenue
28
Enterprise Value EBITDA
-3
318.47
2.39%568.47
2.32%81.44
1.94%111.90
1.15%468.57
0.99%550.56
0.51%547.60
0.00%203.85
0.00%99.06
-1.90%157.11
-1.81%